ArticleBMC musculoskeletal disorders2012

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study.

Aatke van der Maas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.